首页> World journal of surgical oncology> Postoperative adjuvant therapy for stage IA-IIA cervical adenocarcinoma (FIGO 2018) with one intermediate-risk factor: a multicentre retrospective cohort study of 63,926 cases.

Postoperative adjuvant therapy for stage IA-IIA cervical adenocarcinoma (FIGO 2018) with one intermediate-risk factor: a multicentre retrospective cohort study of 63,926 cases.

导出 OA

翻译打印收藏纠错

第一作者： Jiaxin,Fu

第一单位： Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, No. 1838, Guangzhou Avenue, Guangzhou, Guangdong, 510515, China.

作者： Jiaxin,Fu ^[1] ; Cong,Liang ^[1] ; Lixin,Sun ^[2] ; Hongwei,Zhao ^[2] ; Zhumei,Cui ^[3] ; Jinghe,Lang ^[4] ; Chunlin,Chen ^[5] ; Ping,Liu ^[6]

作者单位： Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, No. 1838, Guangzhou Avenue, Guangzhou, Guangdong, 510515, China. ^[1] Department of Gynecologic Oncology, Shanxi Provincial Cancer Hospital, Taiyuan, China. ^[2] Department of The Affiliated Hospital Of Qingdao University, Shandong, China. ^[3] Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Beijing, China. ^[4] Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, No. 1838, Guangzhou Avenue, Guangzhou, Guangdong, 510515, China. ccl1@smu.edu.cn. ^[5] Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, No. 1838, Guangzhou Avenue, Guangzhou, Guangdong, 510515, China. lpivy@126.com. ^[6]

关键词 Adenocarcinoma Adjuvant therapy Cervical cancer FIGO 2018 Intermediate risk factors